|
Optimizing care for Pediatric Patients with
Thyroid Cancer
Dr. Andrew Bauer (USA), Dr. Hanneke Margo van Santen (The Netherlands)
Wednesday, 1 December 2021
14:00 - 15:00 CET (台灣時間 同日21:00-22:00)
|
|
|
In 2015, the American Thyroid Association published inaugural guidelines on the evaluation and management of thyroid nodules and differentiated thyroid cancer in children and adolescents.
Since then, there are new data to improve selection of thyroid nodules for fine needle aspiration as well as stratify individualized surgery and medical care.
|
|
|
In this webinar chaired by Dr. Hanneke Margo van Santen (The Netherlands), Dr. Andrew Bauer (USA) will share new data to improve selection of thyroid nodules for fine needle aspiration as well as stratification of surgical and medical therapy in pediatric patients with thyroid nodules and thyroid cancer.
|
|
|
| Register today and ask your questions to the experts in advance! |
|
|
SAVE YOUR VIRTUAL SEAT HERE, FREE OF CHARGE
When: Wednesday, 1 December, 14:00 - 15:00 CET
After the live webinar, you will be able to access the webinar recording plus a CME/CPD accredited activity around the content of the session on the ISE Global Education Hub, prepared by Dr. Andrew Bauer. Stay tuned to earn your credits.
|
|
|
|
Prepare for the webinar by taking 3 interactive cases on the ISE Global Education Hub developed by Dr. Andrew Bauer
|
|
|
“I would like to invite you to access a series of online case studies I have developed on the Management of Thyroid Nodules and Differentiated Thyroid Cancer in pediatric patients, which are based on my professional experience with patients at the clinic”, says Dr. Andrew Bauer.
Watch Dr. Bauer’s personal invitation here.
|
|
|
|
|
|
Low-Risk Thyroid Cancer in Adults:
Update on Management
Dr. Susan Mandel (USA), Dr. Cosimo Durante (Italy)
Thursday, 9 December 2021
16:00 - 17:00 CET(台灣時間 同日23:00-隔日00:00)
|
|
|
Most patients with differentiated thyroid cancer fall into low-risk stages, where survival is >90%. Therefore, for these patients, initial stratification for risk of structural disease recurrence should be the primary determinant for therapeutic decision-making about surgery, radioiodine, and TSH suppression.
After primary therapy, surveillance data from serum thyroglobulin testing and ultrasound imaging can be used to guide long-term follow-up.
In this webinar chaired by Dr. Cosimo Durante (Italy), Dr. Susan Mandel (USA) will give you the tools to:
|
|
|
• Determine risks for both structural recurrence and disease-specific mortality based upon initial staging of patients with differentiated thyroid cancer.
• Apply evidence-based recommendations to decision making about extent of surgery, I131 therapy and TSH suppression.
• Utilize results from surveillance imaging and thyroglobulin testing to determine long-term follow-up strategies.
|
|
|
| Register today and take the opportunity to ask your questions to the experts in advance. |
|
|
SAVE YOUR VIRTUAL SEAT HERE, FREE OF CHARGE
When: Thursday, 9 December, 16:00 - 17:00 CET
After the live webinar, you will be able to access the recording plus a CME/CPD accredited activity around the content of the session on the ISE Global Education Hub, prepared by Dr. Susan Mandel. Stay tuned to earn your credits.
|
|
|
|
|
|
|
|
Log in to the ISE Global Education Hub to create a free account and access all our educational activities, gain your CME credits and join the more than 1800 endocrinologists worldwide who are already active in our online community!
Do not hesitate to contact us at office@isendo.org if you have any questions or wish further information.
The International Society of Endocrinology
|
|
|
|
